Earnings per Share and Stock-Based Compensation (Tables)

3 Months Ended

Jan. 31, 2014

Reconciliation of Denominator of Each Net Loss per Share

The table below sets forth the reconciliation of the denominator of each net loss per share calculation for the first quarter of fiscal 2014 and 2013:


	First Quarter Ended January 31,
In thousands	2014		2013
Shares used in computing basic net loss per share		169,747		165,767
Dilutive effect of stock options and restricted stock⁽¹⁾		—		—
Dilutive effect of stock warrants⁽¹⁾		—		—

Shares used in computing diluted net loss per share		169,747		165,767

⁽¹⁾

For the first quarter of fiscal 2014 and 2013, the shares used in computing diluted net loss per share do not include 3,974,000 and 3,391,000, respectively, of dilutive stock options and shares of restricted stock, nor 19,913,000 and 15,140,000, respectively, of dilutive warrant shares, as the effect is anti-dilutive given the Company’s net loss from continuing operations. For the first quarter of fiscal 2014 and 2013, additional stock options outstanding of 3,856,000 and 7,932,000, respectively, and additional warrant shares outstanding of 5,741,000 and 10,514,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method.

Schedule of Activity Related to Performance Based Equity Instruments

Activity related to these performance-based equity instruments for the first quarter of fiscal 2014 was as follows:


	Performance Options			Performance Restricted Stock Units
Outstanding, October 31, 2013		688,000			11,675,782
Granted		—			—
Exercised		(12,000	)		—
Canceled		(36,000	)		(30,937	)

Outstanding, January 31, 2014		640,000			11,644,845

Schedule of Changes in Shares under Option, Excluding Performance Based Options

Changes in shares under option, excluding performance-based options, for the first quarter of fiscal 2014 were as follows:


Dollar amounts in thousands, except per share amounts	Shares			Weighted Average Price		Weighted Average Life		Aggregate Intrinsic Value
Outstanding, October 31, 2013		8,829,618		$	4.83
Granted		—			—
Exercised		(568,290	)		4.24			$	2,370
Canceled		(626,750	)		8.59

Outstanding, January 31, 2014		7,634,578		$	4.56		5.5	$	21,110

Options exercisable, January 31, 2014		5,633,427		$	4.16		4.8	$	18,344

Schedule of Changes in Non-Vested Shares under Option, Excluding Performance Based Options

Changes in non-vested shares under option, excluding performance-based options, for the first quarter of fiscal 2014 were as follows:


	Shares			Weighted Average Grant Date Fair Value
Non-vested, October 31, 2013		2,784,826		$	2.95
Granted		—			—
Vested		(778,675	)		2.28
Canceled		(5,000	)		3.51

Non-vested, January 31, 2014		2,001,151		$	3.19